| BSE: 500680 | Sector: Health care |
| NSE: PFIZER | ISIN Code: INE182A01018 |
| BSE 00:00 | 19 Feb | 4220.50 |
92.15 (2.23%) |
OPEN
4166.65 |
HIGH
4273.00 |
LOW
4160.00 |
| NSE 00:00 | 19 Feb | 4220.05 |
90.30 (2.19%) |
OPEN
4178.80 |
HIGH
4275.20 |
LOW
4154.10 |
| OPEN | 4166.65 |
| PREVIOUS CLOSE | 4128.35 |
| VOLUME | 3741 |
| 52-Week high | 4649.40 |
| 52-Week low | 2797.50 |
| P/E | 37.45 |
| Mkt Cap.(Rs cr) | 19,309 |
| Buy Price | 4220.50 |
| Buy Qty | 39.00 |
| Sell Price | 4220.50 |
| Sell Qty | 11.00 |
Pfizer Limited is engaged in manufacturing marketing trading and export of pharmaceutical products. The company is a subsidiary of Pfizer Inc. the world's premiere biopharmaceutical corporation with annual revenues of $52.5 billion in 2017. Pfizer Limited has a portfolio of over 150 products across 15 therapeutic areas. Its top brands include Prevenar 13 Lyrica Eliquis Enbrel Becosules Gelusil and...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
19,309 | |
| EPS - TTM | () |
[*S] | 112.70 |
| P/E Ratio | (X) | [*S] | 37.45 |
| Face Value | () |
10 | |
| Latest Dividend | (%) | 225.00 | |
| Latest Dividend Date | 01 Aug 2019 | ||
| Dividend Yield | (%) | 0.53 | |
| Book Value / Share | () |
[*S] | 689.89 |
| P/B Ratio | () |
[*S] | 6.12 |
Pfizer Q3 net profit climbs 5%, operational revenue up at Rs 514 cr
Pharma shares gain; Dr Reddy's, Alembic, Divis, Laurus Labs hit 52-wk highs
Pfizer planning initial public offering of GSK consumer venture in four yrs
Caplin Steriles gets US FDA approval for generic blood pressure drug
MNC pharma shares in focus; Pfizer, Sanofi India, AstraZeneca hit new high
Announcement under Regulation 30 (LODR)-Change in Directorate
Announcement under Regulation 30 (LODR)-Change in Directorate
Unaudited Financial Results For The Quarter Ended December 31 2019.
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Particulars ( cr) |
Dec 2019 | Dec 2018 | % Chg |
| Net Sales | 538.18 | 513.79 | 4.75 |
| Other Income | 58.22 | 64.35 | -9.53 |
| Total Income | 596.4 | 578.14 | 3.16 |
| Total Expenses | 404.74 | 359.46 | 12.6 |
| Operating Profit | 191.66 | 218.68 | -12.36 |
| Net Profit | 139.06 | 131.94 | 5.4 |
| Equity Capital | 45.75 | 45.75 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Alkem Lab | 2621.25 | 0.03 | 31337.04 |
| Cadila Health. | 276.25 | 3.08 | 28279.71 |
| Glaxosmi. Pharma | 1341.70 | -0.22 | 22729.74 |
| Pfizer | 4220.50 | 2.23 | 19308.79 |
| Ipca Labs. | 1407.85 | 7.19 | 17788.19 |
| Sanofi India | 7176.05 | 0.03 | 16526.44 |
| Alembic Pharma | 671.40 | 3.99 | 12655.89 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -5.42% | -5.18% | -0.58% | -0.62% |
| 1 Month | 4.34% | 4.19% | -1.48% | -1.83% |
| 3 Month | 4.17% | 4.10% | 2.11% | 1.56% |
| 6 Month | 41.00% | 40.90% | 10.48% | 9.70% |
| 1 Year | 45.16% | 44.17% | 16.89% | 14.35% |
| 3 Year | 143.10% | 142.96% | 45.15% | 37.46% |
| Today's Low/High | 4160.00 |
|
4273.00 |
| Week Low/High | 4006.00 |
|
4649.00 |
| Month Low/High | 3981.00 |
|
4649.00 |
| YEAR Low/High | 2797.50 |
|
4649.00 |
| All TIME Low/High | 25.00 |
|
4649.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
